Health
Berlin researchers are pursuing the development of passive vaccination – News-Medical.Net
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité – Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité – Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
In this process, they have also discovered that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects. They report their findi…
-
Noosa News13 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General22 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News19 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business9 hours agoWhere next for the CBA share price?